HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice

por Tyagi, Rajeev K., Jacobse, Justin, Li, Jing, Allaman, Margret M., Otipoby, Kevin L., Sampson, Erik R., Wilson, Keith T., Goettel, Jeremy A.
Publicado 2021

CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients

por Lieberman, Linda A., Zeng, Wanyong, Singh, Carol, Wang, Wenting, Otipoby, Kevin L., Loh, Christine, Plavina, Tatiana, Gorelik, Leonid, Ransohoff, Richard M., Cahir-McFarland, Ellen
Publicado 2016

Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms

por Pellerin, Alex, Otero, Karel, Czerkowicz, Julie M, Kerns, Hannah M, Shapiro, Renée I, Ranger, Ann M, Otipoby, Kevin L, Taylor, Frederick R, Cameron, Thomas O, Viney, Joanne L, Rabah, Dania
Publicado 2015

Basal Immunoglobulin Signaling Actively Maintains Developmental Stage in Immature B Cells

por Tze, Lina E, Schram, Brian R, Lam, Kong-Peng, Hogquist, Kristin A, Hippen, Keli L, Liu, Jiabin, Shinton, Susan A, Otipoby, Kevin L, Rodine, Peter R, Vegoe, Amanda L, Kraus, Manfred, Hardy, Richard R, Schlissel, Mark S, Rajewsky, Klaus, Behrens, Timothy W
Publicado 2005